About
Nuclear Medicines
Areas of Focus
Categories
RadiopharmaceuticalsChina
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
345
By Phase
PHASE1: 2
By Status
RECRUITING: 1UNKNOWN: 1TERMINATED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06492122Lead Sponsor
Study With [225Ac]Ac-FL-020 in mCRPC Participants
PHASE1Recruiting
35 participants
Started: Aug 30, 2024 · Completed: Dec 31, 2026
NCT04437576Collaborator
Pregnancy and Latent Labor Biomarkers and Symptoms to Predict Cervical Dilation at Hospital Admission.
N/AUnknown
300 participants
Started: Sep 13, 2019 · Completed: Jun 1, 2021
NCT04060849Collaborator
Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY
PHASE1Terminated
10 participants
Started: Sep 3, 2019 · Completed: Apr 12, 2020
Locations (1)
Headquarters
Shanghai, China
Map
Loading map...